{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T21:16:20Z","timestamp":1793394980198,"version":"4.5.0"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Translational Medicine and Interdisciplinary Research Joint Fund of Zhongnan Hospital of Wuhan University","award":["ZNJC202321"],"award-info":[{"award-number":["ZNJC202321"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82172841"],"award-info":[{"award-number":["82172841"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","award":["2042022dx0003"],"award-info":[{"award-number":["2042022dx0003"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Hematol Oncol"],"DOI":"10.1186\/s13045-026-01840-4","type":"journal-article","created":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T06:11:26Z","timestamp":1788243086000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Glutathione reductase deficiency potentiates the immunogenicity of ferroptosis and cuproptosis via amplified reactive oxygen species accumulation and cGAS-STING pathway activation"],"prefix":"10.1186","volume":"19","author":[{"given":"Xiaoyi","family":"Deng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zaidong","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruiqi","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changheng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanxun V.","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youngnam N.","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,1]]},"reference":[{"key":"1840_CR1","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.ccell.2020.06.001","volume":"38","author":"JD Hayes","year":"2020","unstructured":"Hayes JD, Dinkova-Kostova AT, Tew KD. Oxidative stress in cancer. Cancer Cell. 2020;38:167\u201397. https:\/\/doi.org\/10.1016\/j.ccell.2020.06.001.","journal-title":"Cancer Cell"},{"key":"1840_CR2","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-025-02375-x","volume":"24","author":"X Liang","year":"2025","unstructured":"Liang X, Weng J, You Z, Wang Y, Wen J, Xia Z, et al. Oxidative stress in cancer: from tumor and microenvironment remodeling to therapeutic frontiers. Mol Cancer. 2025;24:219. https:\/\/doi.org\/10.1186\/s12943-025-02375-x.","journal-title":"Mol Cancer"},{"key":"1840_CR3","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/j.cell.2016.07.002","volume":"166","author":"S Vyas","year":"2016","unstructured":"Vyas S, Zaganjor E, Haigis MC. Mitochondria and cancer. Cell. 2016;166:555\u201366. https:\/\/doi.org\/10.1016\/j.cell.2016.07.002.","journal-title":"Cell"},{"key":"1840_CR4","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.1600200","volume":"2","author":"RJ DeBerardinis","year":"2016","unstructured":"DeBerardinis RJ, Chandel NS. Fundamentals of cancer metabolism. Sci Adv. 2016;2:e1600200. https:\/\/doi.org\/10.1126\/sciadv.1600200.","journal-title":"Sci Adv"},{"key":"1840_CR5","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-017-0648-1","volume":"16","author":"Y Zhao","year":"2017","unstructured":"Zhao Y, Hu X, Liu Y, Dong S, Wen Z, He W, et al. ROS signaling under metabolic stress: cross-talk between AMPK and AKT pathway. Mol Cancer. 2017;16:79. https:\/\/doi.org\/10.1186\/s12943-017-0648-1.","journal-title":"Mol Cancer"},{"issue":"1","key":"1840_CR6","doi-asserted-by":"publisher","first-page":"4728","DOI":"10.1038\/s41467-018-07188-9","volume":"9","author":"F Han","year":"2018","unstructured":"Han F, Li CF, Cai Z, Zhang X, Jin G, Zhang WN, et al. The critical role of AMPK in driving Akt activation under stress, tumorigenesis and drug resistance. Nat Commun. 2018;9(1):4728. https:\/\/doi.org\/10.1038\/s41467-018-07188-9.","journal-title":"Nat Commun"},{"key":"1840_CR7","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1083\/jcb.201102095","volume":"194","author":"T Finkel","year":"2011","unstructured":"Finkel T. Signal transduction by reactive oxygen species. J Cell Biol. 2011;194:7\u201315. https:\/\/doi.org\/10.1083\/jcb.201102095.","journal-title":"J Cell Biol"},{"key":"1840_CR8","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-023-01398-5","volume":"22","author":"MJ Iqbal","year":"2024","unstructured":"Iqbal MJ, Kabeer A, Abbas Z, Siddiqui HA, Calina D, Sharifi-Rad J, et al. Interplay of oxidative stress, cellular communication and signaling pathways in cancer. Cell Commun Signal. 2024;22:7. https:\/\/doi.org\/10.1186\/s12964-023-01398-5.","journal-title":"Cell Commun Signal"},{"key":"1840_CR9","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1038\/s41580-022-00456-z","volume":"23","author":"H Sies","year":"2022","unstructured":"Sies H, Belousov VV, Chandel NS, Davies MJ, Jones DP, Mann GE, et al. Defining roles of specific reactive oxygen species (ROS) in cell biology and physiology. Nat Rev Mol Cell Biol. 2022;23:499\u2013515. https:\/\/doi.org\/10.1038\/s41580-022-00456-z.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1840_CR10","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1016\/j.tcb.2020.03.002","volume":"30","author":"IS Harris","year":"2020","unstructured":"Harris IS, DeNicola GM. The complex interplay between antioxidants and ROS in cancer. Trends Cell Biol. 2020;30:440\u201351. https:\/\/doi.org\/10.1016\/j.tcb.2020.03.002.","journal-title":"Trends Cell Biol"},{"key":"1840_CR11","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1038\/nature10189","volume":"475","author":"GM DeNicola","year":"2011","unstructured":"DeNicola GM, Karreth FA, Humpton TJ, Gopinathan A, Wei C, Frese K, et al. Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis. Nature. 2011;475:106\u20139. https:\/\/doi.org\/10.1038\/nature10189.","journal-title":"Nature"},{"key":"1840_CR12","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/j.cmet.2023.01.012","volume":"35","author":"T Weiss-Sadan","year":"2023","unstructured":"Weiss-Sadan T, Ge M, Hayashi M, Gohar M, Yao C-H, de Groot A, et al. NRF2 activation induces NADH-reductive stress, providing a metabolic vulnerability in lung cancer. Cell Metab. 2023;35:487-503.e7. https:\/\/doi.org\/10.1016\/j.cmet.2023.01.012.","journal-title":"Cell Metab"},{"key":"1840_CR13","doi-asserted-by":"publisher","DOI":"10.3390\/antiox11061128","volume":"11","author":"M Luo","year":"2022","unstructured":"Luo M, Zhou L, Huang Z, Li B, Nice EC, Xu J, et al. Antioxidant therapy in cancer: rationale and progress. Antioxidants (Basel). 2022;11:1128. https:\/\/doi.org\/10.3390\/antiox11061128.","journal-title":"Antioxidants (Basel)"},{"key":"1840_CR14","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1038\/s12276-020-0384-2","volume":"52","author":"B Perillo","year":"2020","unstructured":"Perillo B, Di Donato M, Pezone A, Di Zazzo E, Giovannelli P, Galasso G, et al. ROS in cancer therapy: the bright side of the moon. Exp Mol Med. 2020;52:192\u2013203. https:\/\/doi.org\/10.1038\/s12276-020-0384-2.","journal-title":"Exp Mol Med"},{"key":"1840_CR15","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/j.copbio.2021.03.001","volume":"68","author":"G Asantewaa","year":"2021","unstructured":"Asantewaa G, Harris IS. Glutathione and its precursors in cancer. Curr Opin Biotechnol. 2021;68:292\u20139. https:\/\/doi.org\/10.1016\/j.copbio.2021.03.001.","journal-title":"Curr Opin Biotechnol"},{"key":"1840_CR16","doi-asserted-by":"publisher","first-page":"2291","DOI":"10.1083\/jcb.201804161","volume":"217","author":"A Bansal","year":"2018","unstructured":"Bansal A, Simon MC. Glutathione metabolism in cancer progression and treatment resistance. J Cell Biol. 2018;217:2291\u20138. https:\/\/doi.org\/10.1083\/jcb.201804161.","journal-title":"J Cell Biol"},{"key":"1840_CR17","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1158\/0008-5472.CAN-18-1938","volume":"79","author":"X Yan","year":"2019","unstructured":"Yan X, Zhang X, Wang L, Zhang R, Pu X, Wu S, et al. Inhibition of thioredoxin\/thioredoxin reductase induces synthetic lethality in lung cancers with compromised glutathione homeostasis. Cancer Res. 2019;79:125\u201332. https:\/\/doi.org\/10.1158\/0008-5472.CAN-18-1938.","journal-title":"Cancer Res"},{"key":"1840_CR18","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.freeradbiomed.2009.04.022","volume":"47","author":"Y Zhao","year":"2009","unstructured":"Zhao Y, Seefeldt T, Chen W, Carlson L, Stoebner A, Hanson S, et al. Increase in thiol oxidative stress via glutathione reductase inhibition as a novel approach to enhance cancer sensitivity to X-ray irradiation. Free Radic Biol Med. 2009;47:176. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2009.04.022.","journal-title":"Free Radic Biol Med"},{"key":"1840_CR19","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1038\/s41568-021-00435-0","volume":"22","author":"EC Cheung","year":"2022","unstructured":"Cheung EC, Vousden KH. The role of ROS in tumour development and progression. Nat Rev Cancer. 2022;22:280\u201397. https:\/\/doi.org\/10.1038\/s41568-021-00435-0.","journal-title":"Nat Rev Cancer"},{"key":"1840_CR20","doi-asserted-by":"publisher","first-page":"e1505","DOI":"10.1038\/cddis.2014.465","volume":"5","author":"CRR Rocha","year":"2014","unstructured":"Rocha CRR, Garcia CCM, Vieira DB, Quinet A, de Andrade-Lima LC, Munford V, et al. Glutathione depletion sensitizes cisplatin- and temozolomide-resistant glioma cells in vitro and in vivo. Cell Death Dis Nature Publishing Group. 2014;5:e1505\u2013e1505. https:\/\/doi.org\/10.1038\/cddis.2014.465.","journal-title":"Cell Death Dis Nature Publishing Group"},{"key":"1840_CR21","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","volume":"149","author":"SJ Dixon","year":"2012","unstructured":"Dixon SJ, Lemberg KM, Lamprecht MR, Skouta R, Zaitsev EM, Gleason CE, et al. Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell. 2012;149:1060\u201372. https:\/\/doi.org\/10.1016\/j.cell.2012.03.042.","journal-title":"Cell"},{"key":"1840_CR22","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1021\/acscentsci.7b00589","volume":"4","author":"R Shah","year":"2018","unstructured":"Shah R, Shchepinov MS, Pratt DA. Resolving the role of lipoxygenases in the initiation and execution of ferroptosis. ACS Cent Sci. 2018;4:387\u201396. https:\/\/doi.org\/10.1021\/acscentsci.7b00589.","journal-title":"ACS Cent Sci"},{"key":"1840_CR23","doi-asserted-by":"publisher","first-page":"2748","DOI":"10.1016\/j.cell.2023.05.003","volume":"186","author":"D Liang","year":"2023","unstructured":"Liang D, Feng Y, Zandkarimi F, Wang H, Zhang Z, Kim J, et al. Ferroptosis surveillance independent of GPX4 and differentially regulated by sex hormones. Cell. 2023;186:2748-2764.e22. https:\/\/doi.org\/10.1016\/j.cell.2023.05.003.","journal-title":"Cell"},{"key":"1840_CR24","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.cell.2013.12.010","volume":"156","author":"WS Yang","year":"2014","unstructured":"Yang WS, SriRamaratnam R, Welsch ME, Shimada K, Skouta R, Viswanathan VS, et al. Regulation of ferroptotic cancer cell death by GPX4. Cell. 2014;156:317\u201331. https:\/\/doi.org\/10.1016\/j.cell.2013.12.010.","journal-title":"Cell"},{"key":"1840_CR25","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.02523","volume":"3","author":"SJ Dixon","year":"2014","unstructured":"Dixon SJ, Patel DN, Welsch M, Skouta R, Lee ED, Hayano M, et al. Pharmacological inhibition of cystine\u2013glutamate exchange induces endoplasmic reticulum stress and ferroptosis. Elife. 2014;3:e02523. https:\/\/doi.org\/10.7554\/eLife.02523.","journal-title":"Elife"},{"key":"1840_CR26","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.cmet.2008.07.005","volume":"8","author":"A Seiler","year":"2008","unstructured":"Seiler A, Schneider M, F\u00f6rster H, Roth S, Wirth EK, Culmsee C, et al. Glutathione peroxidase 4 senses and translates oxidative stress into 12\/15-lipoxygenase dependent- and AIF-mediated cell death. Cell Metab. 2008;8:237\u201348. https:\/\/doi.org\/10.1016\/j.cmet.2008.07.005.","journal-title":"Cell Metab"},{"key":"1840_CR27","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1038\/nature24297","volume":"551","author":"MJ Hangauer","year":"2017","unstructured":"Hangauer MJ, Viswanathan VS, Ryan MJ, Bole D, Eaton JK, Matov A, et al. Drug-tolerant persister cancer cells are vulnerable to GPX4 inhibition. Nature. 2017;551:247\u201350. https:\/\/doi.org\/10.1038\/nature24297.","journal-title":"Nature"},{"key":"1840_CR28","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nature23007","volume":"547","author":"VS Viswanathan","year":"2017","unstructured":"Viswanathan VS, Ryan MJ, Dhruv HD, Gill S, Eichhoff OM, Seashore-Ludlow B, et al. Dependency of a therapy-resistant state of cancer cells on a lipid peroxidase pathway. Nature. 2017;547:453\u20137. https:\/\/doi.org\/10.1038\/nature23007.","journal-title":"Nature"},{"key":"1840_CR29","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.cmet.2022.09.021","volume":"35","author":"F Yang","year":"2023","unstructured":"Yang F, Xiao Y, Ding J-H, Jin X, Ma D, Li D-Q, et al. Ferroptosis heterogeneity in triple-negative breast cancer reveals an innovative immunotherapy combination strategy. Cell Metab. 2023;35:84-100.e8. https:\/\/doi.org\/10.1016\/j.cmet.2022.09.021.","journal-title":"Cell Metab"},{"key":"1840_CR30","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1016\/j.molcel.2021.12.001","volume":"82","author":"R Rodriguez","year":"2022","unstructured":"Rodriguez R, Schreiber SL, Conrad M. Persister cancer cells: iron addiction and vulnerability to ferroptosis. Mol Cell. 2022;82:728\u201340. https:\/\/doi.org\/10.1016\/j.molcel.2021.12.001.","journal-title":"Mol Cell"},{"key":"1840_CR31","doi-asserted-by":"publisher","first-page":"1568","DOI":"10.1016\/j.chembiol.2022.08.008","volume":"29","author":"L Magtanong","year":"2022","unstructured":"Magtanong L, Mueller GD, Williams KJ, Billmann M, Chan K, Armenta DA, et al. Context-dependent regulation of ferroptosis sensitivity. Cell Chem Biol. 2022;29:1568. https:\/\/doi.org\/10.1016\/j.chembiol.2022.08.008.","journal-title":"Cell Chem Biol"},{"key":"1840_CR32","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/s41568-019-0149-1","volume":"19","author":"JP Friedmann Angeli","year":"2019","unstructured":"Friedmann Angeli JP, Krysko DV, Conrad M. Ferroptosis at the crossroads of cancer-acquired drug resistance and immune evasion. Nat Rev Cancer. 2019;19:405\u201314. https:\/\/doi.org\/10.1038\/s41568-019-0149-1.","journal-title":"Nat Rev Cancer"},{"key":"1840_CR33","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1126\/science.abf0529","volume":"375","author":"P Tsvetkov","year":"2022","unstructured":"Tsvetkov P, Coy S, Petrova B, Dreishpoon M, Verma A, Abdusamad M, et al. Copper induces cell death by targeting lipoylated TCA cycle proteins. Science. 2022;375:1254\u201361. https:\/\/doi.org\/10.1126\/science.abf0529.","journal-title":"Science"},{"key":"1840_CR34","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-025-02192-0","author":"Z Guo","year":"2025","unstructured":"Guo Z, Chen D, Yao L, Sun Y, Li D, Le J, et al. The molecular mechanism and therapeutic landscape of copper and cuproptosis in cancer. Sig Transduct Target Ther. 2025. https:\/\/doi.org\/10.1038\/s41392-025-02192-0.","journal-title":"Sig Transduct Target Ther."},{"key":"1840_CR35","doi-asserted-by":"publisher","first-page":"1786","DOI":"10.1016\/j.molcel.2022.05.001","volume":"82","author":"PA Cobine","year":"2022","unstructured":"Cobine PA, Brady DC. Cuproptosis: cellular and molecular mechanisms underlying copper-induced cell death. Mol Cell. 2022;82:1786\u20137. https:\/\/doi.org\/10.1016\/j.molcel.2022.05.001.","journal-title":"Mol Cell"},{"key":"1840_CR36","doi-asserted-by":"publisher","first-page":"2401","DOI":"10.1016\/j.cell.2022.06.003","volume":"185","author":"BR Stockwell","year":"2022","unstructured":"Stockwell BR. Ferroptosis turns 10: emerging mechanisms, physiological functions, and therapeutic applications. Cell. 2022;185:2401\u201321. https:\/\/doi.org\/10.1016\/j.cell.2022.06.003.","journal-title":"Cell"},{"key":"1840_CR37","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/nri.2016.107","volume":"17","author":"L Galluzzi","year":"2017","unstructured":"Galluzzi L, Buqu\u00e9 A, Kepp O, Zitvogel L, Kroemer G. Immunogenic cell death in cancer and infectious disease. Nat Rev Immunol. 2017;17:97\u2013111. https:\/\/doi.org\/10.1038\/nri.2016.107.","journal-title":"Nat Rev Immunol"},{"key":"1840_CR38","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1038\/nrc3380","volume":"12","author":"DV Krysko","year":"2012","unstructured":"Krysko DV, Garg AD, Kaczmarek A, Krysko O, Agostinis P, Vandenabeele P. Immunogenic cell death and DAMPs in cancer therapy. Nat Rev Cancer. 2012;12:860\u201375. https:\/\/doi.org\/10.1038\/nrc3380.","journal-title":"Nat Rev Cancer"},{"key":"1840_CR39","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1038\/nm1523","volume":"13","author":"M Obeid","year":"2007","unstructured":"Obeid M, Tesniere A, Ghiringhelli F, Fimia GM, Apetoh L, Perfettini J-L, et al. Calreticulin exposure dictates the immunogenicity of cancer cell death. Nat Med Nature Publishing Group. 2007;13:54\u201361. https:\/\/doi.org\/10.1038\/nm1523.","journal-title":"Nat Med Nature Publishing Group"},{"key":"1840_CR40","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1111\/imr.12601","volume":"280","author":"ME Bianchi","year":"2017","unstructured":"Bianchi ME, Crippa MP, Manfredi AA, Mezzapelle R, Rovere Querini P, Venereau E. High-mobility group box 1 protein orchestrates responses to tissue damage via inflammation, innate and adaptive immunity, and tissue repair. Immunol Rev. 2017;280:74\u201382. https:\/\/doi.org\/10.1111\/imr.12601.","journal-title":"Immunol Rev"},{"key":"1840_CR41","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1038\/nature00858","volume":"418","author":"P Scaffidi","year":"2002","unstructured":"Scaffidi P, Misteli T, Bianchi ME. Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature. 2002;418:191\u20135. https:\/\/doi.org\/10.1038\/nature00858.","journal-title":"Nature"},{"key":"1840_CR42","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2020-001369","author":"I Efimova","year":"2020","unstructured":"Efimova I, Catanzaro E, der Meeren LV, Turubanova VD, Hammad H, Mishchenko TA, et al. Vaccination with early ferroptotic cancer cells induces efficient antitumor immunity. J Immunother Cancer. 2020. https:\/\/doi.org\/10.1136\/jitc-2020-001369.","journal-title":"J Immunother Cancer"},{"key":"1840_CR43","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-17204-5","volume":"7","author":"P Bankhead","year":"2017","unstructured":"Bankhead P, Loughrey MB, Fern\u00e1ndez JA, Dombrowski Y, McArt DG, Dunne PD, et al. QuPath: open source software for digital pathology image analysis. Sci Rep. 2017;7:16878. https:\/\/doi.org\/10.1038\/s41598-017-17204-5. (Nature Publishing Group).","journal-title":"Sci Rep"},{"key":"1840_CR44","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1038\/nature14156","volume":"520","author":"AP West","year":"2015","unstructured":"West AP, Khoury-Hanold W, Staron M, Tal MC, Pineda CM, Lang SM, et al. Mitochondrial DNA stress primes the antiviral innate immune response. Nature. 2015;520:553\u20137. https:\/\/doi.org\/10.1038\/nature14156.","journal-title":"Nature"},{"key":"1840_CR45","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1038\/s41591-018-0136-1","volume":"24","author":"P Jiang","year":"2018","unstructured":"Jiang P, Gu S, Pan D, Fu J, Sahu A, Hu X, et al. Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response. Nat Med. 2018;24:1550\u20138. https:\/\/doi.org\/10.1038\/s41591-018-0136-1.","journal-title":"Nat Med"},{"key":"1840_CR46","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nmeth.3337","volume":"12","author":"AM Newman","year":"2015","unstructured":"Newman AM, Liu CL, Green MR, Gentles AJ, Feng W, Xu Y, et al. Robust enumeration of cell subsets from tissue expression profiles. Nat Methods Nature Publishing Group. 2015;12:453\u20137. https:\/\/doi.org\/10.1038\/nmeth.3337.","journal-title":"Nat Methods Nature Publishing Group"},{"key":"1840_CR47","doi-asserted-by":"publisher","DOI":"10.1002\/imt2.229","volume":"3","author":"Y Chen","year":"2024","unstructured":"Chen Y, He L-N, Zhang Y, Gong J, Xu S, Shu Y, et al. TigeR: tumor immunotherapy gene expression data analysis R package. iMeta. 2024;3:e229. https:\/\/doi.org\/10.1002\/imt2.229.","journal-title":"iMeta"},{"key":"1840_CR48","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1016\/j.bcp.2005.02.016","volume":"69","author":"KP Rice","year":"2005","unstructured":"Rice KP, Penketh PG, Shyam K, Sartorelli AC. Differential inhibition of cellular glutathione reductase activity by isocyanates generated from the antitumor prodrugs Cloretazine\u2122 and BCNU. Biochem Pharmacol. 2005;69:1463\u201372. https:\/\/doi.org\/10.1016\/j.bcp.2005.02.016.","journal-title":"Biochem Pharmacol"},{"key":"1840_CR49","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2022.110343","author":"FD Johnson","year":"2022","unstructured":"Johnson FD, Ferrarone J, Liu A, Brandst\u00e4dter C, Munuganti R, Farnsworth DA, et al. Characterization of a small molecule inhibitor of disulfide reductases that induces oxidative stress and lethality in lung cancer cells. Cell Rep. 2022. https:\/\/doi.org\/10.1016\/j.celrep.2022.110343. (Elsevier).","journal-title":"Cell Rep"},{"key":"1840_CR50","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.cbi.2007.01.005","volume":"167","author":"M Hultberg","year":"2007","unstructured":"Hultberg M, Isaksson A, Andersson A, Hultberg B. Traces of copper ions deplete glutathione in human hepatoma cell cultures with low cysteine content. Chem Biol Interact. 2007;167:56\u201362. https:\/\/doi.org\/10.1016\/j.cbi.2007.01.005.","journal-title":"Chem Biol Interact"},{"key":"1840_CR51","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1016\/j.immuni.2022.06.007","volume":"55","author":"H Xian","year":"2022","unstructured":"Xian H, Watari K, Sanchez-Lopez E, Offenberger J, Onyuru J, Sampath H, et al. Oxidized DNA fragments exit mitochondria via mPTP- and VDAC-dependent channels to activate NLRP3 inflammasome and interferon signaling. Immunity. 2022;55:1370-1385.e8. https:\/\/doi.org\/10.1016\/j.immuni.2022.06.007.","journal-title":"Immunity"},{"key":"1840_CR52","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-024-05588-8","volume":"22","author":"Y Xiong","year":"2024","unstructured":"Xiong Y, Chen J, Liang W, Li K, Huang Y, Song J, et al. Blockade of the mitochondrial DNA release ameliorates hepatic ischemia-reperfusion injury through avoiding the activation of cGAS-Sting pathway. J Transl Med. 2024;22:796. https:\/\/doi.org\/10.1186\/s12967-024-05588-8.","journal-title":"J Transl Med"},{"key":"1840_CR53","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1038\/s12276-023-00965-7","volume":"55","author":"J Kim","year":"2023","unstructured":"Kim J, Kim H-S, Chung JH. Molecular mechanisms of mitochondrial DNA release and activation of the cGAS-STING pathway. Exp Mol Med. 2023;55:510\u20139. https:\/\/doi.org\/10.1038\/s12276-023-00965-7.","journal-title":"Exp Mol Med"},{"key":"1840_CR54","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1038\/nri.2017.21","volume":"17","author":"AP West","year":"2017","unstructured":"West AP, Shadel GS. Mitochondrial DNA in innate immune responses and inflammatory pathology. Nat Rev Immunol. 2017;17:363\u201375. https:\/\/doi.org\/10.1038\/nri.2017.21.","journal-title":"Nat Rev Immunol"},{"key":"1840_CR55","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-025-02603-3","volume":"24","author":"Y Jing","year":"2025","unstructured":"Jing Y, Zhang Y, Kadier T, Ding K, Chen R, Meng Q. Mitochondrial DNA release via mPTP and BAX\/BAK drives inflammatory injury in intestinal ischemia reperfusion. Cell Commun Signal. 2025;24:50. https:\/\/doi.org\/10.1186\/s12964-025-02603-3.","journal-title":"Cell Commun Signal"},{"key":"1840_CR56","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2025.103719","volume":"85","author":"M Ioannidis","year":"2025","unstructured":"Ioannidis M, Tjepkema J, Uitbeijerse MRP, van den Bogaart G. Immunomodulatory effects of 4-hydroxynonenal. Redox Biol. 2025;85:103719. https:\/\/doi.org\/10.1016\/j.redox.2025.103719.","journal-title":"Redox Biol"},{"key":"1840_CR57","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-31218-2","volume":"13","author":"B Wiernicki","year":"2022","unstructured":"Wiernicki B, Maschalidi S, Pinney J, Adjemian S, Vanden Berghe T, Ravichandran KS, et al. Cancer cells dying from ferroptosis impede dendritic cell-mediated anti-tumor immunity. Nat Commun. 2022;13:3676. https:\/\/doi.org\/10.1038\/s41467-022-31218-2.","journal-title":"Nat Commun"},{"key":"1840_CR58","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1038\/s41586-022-05443-0","volume":"612","author":"R Kim","year":"2022","unstructured":"Kim R, Hashimoto A, Markosyan N, Tyurin VA, Tyurina YY, Kar G, et al. Ferroptosis of tumour neutrophils causes immune suppression in cancer. Nature. 2022;612:338\u201346. https:\/\/doi.org\/10.1038\/s41586-022-05443-0.","journal-title":"Nature"},{"key":"1840_CR59","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-024-01769-5","volume":"9","author":"Q Zhou","year":"2024","unstructured":"Zhou Q, Meng Y, Li D, Yao L, Le J, Liu Y, et al. Ferroptosis in cancer: from molecular mechanisms to therapeutic strategies. Sig Transduct Target Ther. 2024;9:55. https:\/\/doi.org\/10.1038\/s41392-024-01769-5.","journal-title":"Sig Transduct Target Ther"},{"key":"1840_CR60","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-026-72737-6","author":"M Saviuk","year":"2026","unstructured":"Saviuk M, Turubanova VD, De Br\u00e9e S, Van Lint S, Maia TM, Devos S, et al. Ferroptosis-armed dendritic cell vaccines for glioma immunotherapy. Nat Commun. 2026. https:\/\/doi.org\/10.1038\/s41467-026-72737-6.","journal-title":"Nat Commun"},{"key":"1840_CR61","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.trecan.2024.01.013","volume":"10","author":"E Catanzaro","year":"2024","unstructured":"Catanzaro E, Demuynck R, Naessens F, Galluzzi L, Krysko DV. Immunogenicity of ferroptosis in cancer: a matter of context? Trends Cancer. 2024;10:407\u201316. https:\/\/doi.org\/10.1016\/j.trecan.2024.01.013.","journal-title":"Trends Cancer"},{"key":"1840_CR62","doi-asserted-by":"publisher","first-page":"4582","DOI":"10.1016\/j.apsb.2025.07.007","volume":"15","author":"R Zhang","year":"2025","unstructured":"Zhang R, Li Y, Fu H, Zhao C, Li X, Wang Y, et al. Nanomedicine strategies for cuproptosis: metabolic reprogramming and tumor immunotherapy. Acta Pharm Sin B. 2025;15:4582\u2013613. https:\/\/doi.org\/10.1016\/j.apsb.2025.07.007.","journal-title":"Acta Pharm Sin B"},{"key":"1840_CR63","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-54469-7","volume":"15","author":"M Guan","year":"2024","unstructured":"Guan M, Cheng K, Xie X-T, Li Y, Ma M-W, Zhang B, et al. Regulating copper homeostasis of tumor cells to promote cuproptosis for enhancing breast cancer immunotherapy. Nat Commun. 2024;15:10060. https:\/\/doi.org\/10.1038\/s41467-024-54469-7.","journal-title":"Nat Commun"},{"key":"1840_CR64","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2025.123201","volume":"319","author":"J Li","year":"2025","unstructured":"Li J, Zhang G, Sun Z, Jiang M, Jia G, Liu H, et al. Immunogenic cuproptosis in cancer immunotherapy via an in situ cuproptosis-inducing system. Biomaterials. 2025;319:123201. https:\/\/doi.org\/10.1016\/j.biomaterials.2025.123201.","journal-title":"Biomaterials"},{"key":"1840_CR65","doi-asserted-by":"publisher","first-page":"3988","DOI":"10.1021\/jacsau.4c00712","volume":"4","author":"C Zhu","year":"2024","unstructured":"Zhu C, Li J, Sun W, Li D, Wang Y, Shen X-C. Signaling mechanism of cuproptosis activating cGAS-STING immune pathway. JACS Au. 2024;4:3988\u201399. https:\/\/doi.org\/10.1021\/jacsau.4c00712.","journal-title":"JACS Au"},{"key":"1840_CR66","doi-asserted-by":"publisher","first-page":"33440","DOI":"10.18632\/oncotarget.7961","volume":"7","author":"X Li","year":"2016","unstructured":"Li X, Wu C, Chen N, Gu H, Yen A, Cao L, et al. PI3K\/Akt\/mTOR signaling pathway and targeted therapy for glioblastoma. Oncotarget. 2016;7:33440\u201350. https:\/\/doi.org\/10.18632\/oncotarget.7961.","journal-title":"Oncotarget"},{"key":"1840_CR67","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-025-14151-7","volume":"25","author":"Y Wang","year":"2025","unstructured":"Wang Y, Qiao S, Wang P, Li M, Ma X, Wang H, et al. Copper\u2019s new role in cancer: how cuproptosis-related genes could revolutionize glioma treatment. BMC Cancer. 2025;25:859. https:\/\/doi.org\/10.1186\/s12885-025-14151-7.","journal-title":"BMC Cancer"},{"key":"1840_CR68","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1158\/1541-7786.MCR-16-0028","volume":"14","author":"MD Polewski","year":"2016","unstructured":"Polewski MD, Reveron-Thornton RF, Cherryholmes GA, Marinov GK, Cassady K, Aboody KS. Increased expression of system xc\u2212 in glioblastoma confers an altered metabolic state and temozolomide resistance. Mol Cancer Res. 2016;14:1229\u201342. https:\/\/doi.org\/10.1158\/1541-7786.MCR-16-0028.","journal-title":"Mol Cancer Res"},{"key":"1840_CR69","doi-asserted-by":"publisher","first-page":"2142","DOI":"10.1016\/j.freeradbiomed.2012.03.017","volume":"52","author":"M Nagai","year":"2012","unstructured":"Nagai M, Vo NH, Shin Ogawa L, Chimmanamada D, Inoue T, Chu J, et al. The oncology drug elesclomol selectively transports copper to the mitochondria to induce oxidative stress in cancer cells. Free Radic Biol Med. 2012;52:2142\u201350. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2012.03.017.","journal-title":"Free Radic Biol Med"},{"key":"1840_CR70","doi-asserted-by":"publisher","first-page":"9518","DOI":"10.18632\/aging.205881","volume":"16","author":"Z Deng","year":"2024","unstructured":"Deng Z, Luo J, Ma J, Jin YN, Yu YV. Glutathione metabolism-related gene signature predicts prognosis and treatment response in low-grade glioma. Aging (Albany NY). 2024;16:9518\u201346. https:\/\/doi.org\/10.18632\/aging.205881.","journal-title":"Aging (Albany NY)"},{"key":"1840_CR71","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1038\/s41590-020-0699-0","volume":"21","author":"M Jia","year":"2020","unstructured":"Jia M, Qin D, Zhao C, Chai L, Yu Z, Wang W, et al. Redox homeostasis maintained by GPX4 facilitates STING activation. Nat Immunol. 2020;21:727\u201335. https:\/\/doi.org\/10.1038\/s41590-020-0699-0.","journal-title":"Nat Immunol"}],"container-title":["Journal of Hematology & Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13045-026-01840-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13045-026-01840-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13045-026-01840-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T06:11:27Z","timestamp":1788243087000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13045-026-01840-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,1]]},"references-count":71,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1840"],"URL":"https:\/\/doi.org\/10.1186\/s13045-026-01840-4","relation":{},"ISSN":["1756-8722"],"issn-type":[{"value":"1756-8722","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,1]]},"assertion":[{"value":"5 July 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All research in this paper was conducted in full compliance with all applicable ethical standards and regulations. All animal experiments were conducted under protocol (MRI2023-LAC165), which was reviewed and approved by the Laboratory Animal Ethics Committee of Wuhan University. Consent to Participate: not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"61"}}